Table 2.

Immunophenotypic features of studied genetic subtypes.

Antigen	ETV6::RUNX1	BCR::ABL1	KMT2A	TCF3::PBX1	Hyper-Diploidy	Prognosis if +	EGIL Subtype if +
CD10	+ [32,33,35,47,62]	+ [6,22,32,34]	− [10,13,32,33,59]	+/− [13,32]	+ [11,32]	Good [26]	B-II [13,31]
CD66c	− [13,32,38,73]	+ [13,21,32,37,38,39]	− [6,32,38]	− [32,38]	+ [11,32,33]	Inconclusive	Irrelevant
NG2	− [32]	− [32]	+ [10,25,26,32,33]	− [32]	[32]	Poor [3,25,26]	B-I [10,26,32]
TSLPR	ND	ND	ND	ND	ND	Poor [24,42,43]	Irrelevant
CD123	Low + [45]	+ [44]	+ [6]	− [6]	+ [1,33,44,45,46,74]	Good [3,45]	B-II [45]
CD9	− [6,13,14,32,47]	+ [6]	+ [6,32]	+ [6,32]	ND	Poor [14,47]	Irrelevant
CD38	+ [1,33]	− [6,34]	+ [6]	+ [6]	− [1]	Inconclusive [1,50]	Irrelevant
CD45	Low+ [16,32,33,62]	−/Low+ [32]	Low+ [32]	Low + [32]	− [11,32,53]	Poor [4,51,52]	Irrelevant
CD20	− [13,16,32,62]	+ [32]	− [6,13,32,59]	Low + [13,32]	Low+ [32]	Inconclusive [39,54]	Irrelevant
CD24	+ [13,32]	+ [13,32]	− [13,26,32,33]	+ [32]	+ [32]	Inconclusive	B-IV [56,57]
CD22	Low+ [32]	Low+ [32]	− [32,59]	+ [32]	+ [32]	Inconclusive	All [13,31]
CD13	+ [13,22,32]	+ [16,32,34,39,62]	− [32]	− [32]	− [32]	Inconclusive	Irrelevant
cIgM	− [32]	− [32]	− [6,32]	+ [6,10,15,32]	− [32]	Poor	B-III [13,31,63,64]
CD15	− [32,62]	− [6,32,39]	+ [6,10,13,26,32,59]	− [32]	− [32]	Poor	B-I [13]
CD33	+ [13,32]	+ [13,22,39]	− [32]	− [32]	− [32]	Poor [1]	Irrelevant
TdT	+ [13,32]	+ [13,32]	Low+ [33]/ + [13,32]	+[32]	+[32]	Inconclusive	B-I, II, III [13,31]
CD81	Low+/−[33]	ND	− [33]	ND	− [33]	Good	Irrelevant
CD34	Low+ [33]/ + [6,13,32,62]	+ [6,13,34]	− [6,32,33]	− [6,13,32]	+ [32,33]	Inconclusive	Irrelevant